SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551986-20-000066
Filing Date
2020-04-22
Accepted
2020-04-22 16:19:16
Documents
3
Period of Report
2020-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K a8-kitem10122apr20.htm 8-K 36387
2 EXHIBIT 99.1 ex-991ppppromissorynote.htm EX-99.1 50510
3 ex991ppppromissorynot_image1.jpg GRAPHIC 13669
  Complete submission text file 0001551986-20-000066.txt   107293
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 20808150
SIC: 2834 Pharmaceutical Preparations